glp-1 for anxiety medications used to treat diabetes and obesity may also help alleviate symptoms of and depression New Study: GLP-1s REDUCED Depression

This is different from FDA-approved brand-name medications referenced separately on altRx (Wegovy, Ozempic, Mounjaro, Zepbound), which are listed at substantially higher monthly price points

There was a mistake not on their part regarding a teladoc appointment

Overall, middle-income markets in Asia and Latin America are emerging as key drivers of global market expansion as treatment access improves and physician familiarity with GLP-1 medications increases

In the obesity group, there was a significant and clinically meaningful reduction in body weight of 4.74% at week 8, with weight continuously decreasing during the 8-week treatment period